The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Coagulation Factor IX-Global Market Insights and Sales Trends 2025
Synopsis
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market size is expected to reach US$ 526 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Coagulation Factor IX in various end use industries. The expanding demands from the Adult and Kids, are propelling Coagulation Factor IX market. Coagulation Factor IX (Plasma Derived), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coagulation Factor IX (Recombinant) segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Coagulation Factor IX, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Coagulation Factor IX market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Coagulation Factor IX market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Coagulation Factor IX sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Coagulation Factor IX covered in this report include Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter and Aptevo, etc.
The global Coagulation Factor IX market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Global Coagulation Factor IX market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Coagulation Factor IX market, Segment by Type:
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Global Coagulation Factor IX market, by Application
Adult
Kids
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market size is expected to reach US$ 526 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Coagulation Factor IX in various end use industries. The expanding demands from the Adult and Kids, are propelling Coagulation Factor IX market. Coagulation Factor IX (Plasma Derived), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coagulation Factor IX (Recombinant) segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Coagulation Factor IX, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Coagulation Factor IX market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Coagulation Factor IX market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Coagulation Factor IX sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Coagulation Factor IX covered in this report include Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter and Aptevo, etc.
The global Coagulation Factor IX market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Global Coagulation Factor IX market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Coagulation Factor IX market, Segment by Type:
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Global Coagulation Factor IX market, by Application
Adult
Kids
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Coagulation Factor IX Market Overview
1.1 Coagulation Factor IX Product Overview
1.2 Coagulation Factor IX Market Segment by Type
1.2.1 Coagulation Factor IX (Plasma Derived)
1.2.2 Coagulation Factor IX (Recombinant)
1.3 Global Coagulation Factor IX Market Size by Type
1.3.1 Global Coagulation Factor IX Market Size Overview by Type (2018-2029)
1.3.2 Global Coagulation Factor IX Historic Market Size Review by Type (2018-2023)
1.3.3 Global Coagulation Factor IX Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Coagulation Factor IX Sales Breakdown by Type (2018-2023)
1.4.2 Europe Coagulation Factor IX Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Coagulation Factor IX Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Coagulation Factor IX Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Coagulation Factor IX Sales Breakdown by Type (2018-2023)
2 Global Coagulation Factor IX Market Competition by Company
2.1 Global Top Players by Coagulation Factor IX Sales (2018-2023)
2.2 Global Top Players by Coagulation Factor IX Revenue (2018-2023)
2.3 Global Top Players by Coagulation Factor IX Price (2018-2023)
2.4 Global Top Manufacturers Coagulation Factor IX Manufacturing Base Distribution, Sales Area, Product Type
2.5 Coagulation Factor IX Market Competitive Situation and Trends
2.5.1 Coagulation Factor IX Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Coagulation Factor IX Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coagulation Factor IX as of 2022)
2.7 Date of Key Manufacturers Enter into Coagulation Factor IX Market
2.8 Key Manufacturers Coagulation Factor IX Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Coagulation Factor IX Status and Outlook by Region
3.1 Global Coagulation Factor IX Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Coagulation Factor IX Historic Market Size by Region
3.2.1 Global Coagulation Factor IX Sales in Volume by Region (2018-2023)
3.2.2 Global Coagulation Factor IX Sales in Value by Region (2018-2023)
3.2.3 Global Coagulation Factor IX Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Coagulation Factor IX Forecasted Market Size by Region
3.3.1 Global Coagulation Factor IX Sales in Volume by Region (2024-2029)
3.3.2 Global Coagulation Factor IX Sales in Value by Region (2024-2029)
3.3.3 Global Coagulation Factor IX Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Coagulation Factor IX by Application
4.1 Coagulation Factor IX Market Segment by Application
4.1.1 Adult
4.1.2 Kids
4.2 Global Coagulation Factor IX Market Size by Application
4.2.1 Global Coagulation Factor IX Market Size Overview by Application (2018-2029)
4.2.2 Global Coagulation Factor IX Historic Market Size Review by Application (2018-2023)
4.2.3 Global Coagulation Factor IX Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Coagulation Factor IX Sales Breakdown by Application (2018-2023)
4.3.2 Europe Coagulation Factor IX Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Coagulation Factor IX Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Coagulation Factor IX Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Coagulation Factor IX Sales Breakdown by Application (2018-2023)
5 North America Coagulation Factor IX by Country
5.1 North America Coagulation Factor IX Historic Market Size by Country
5.1.1 North America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Coagulation Factor IX Sales in Volume by Country (2018-2023)
5.1.3 North America Coagulation Factor IX Sales in Value by Country (2018-2023)
5.2 North America Coagulation Factor IX Forecasted Market Size by Country
5.2.1 North America Coagulation Factor IX Sales in Volume by Country (2024-2029)
5.2.2 North America Coagulation Factor IX Sales in Value by Country (2024-2029)
6 Europe Coagulation Factor IX by Country
6.1 Europe Coagulation Factor IX Historic Market Size by Country
6.1.1 Europe Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Coagulation Factor IX Sales in Volume by Country (2018-2023)
6.1.3 Europe Coagulation Factor IX Sales in Value by Country (2018-2023)
6.2 Europe Coagulation Factor IX Forecasted Market Size by Country
6.2.1 Europe Coagulation Factor IX Sales in Volume by Country (2024-2029)
6.2.2 Europe Coagulation Factor IX Sales in Value by Country (2024-2029)
7 Asia-Pacific Coagulation Factor IX by Region
7.1 Asia-Pacific Coagulation Factor IX Historic Market Size by Region
7.1.1 Asia-Pacific Coagulation Factor IX Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Coagulation Factor IX Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Coagulation Factor IX Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Coagulation Factor IX Forecasted Market Size by Region
7.2.1 Asia-Pacific Coagulation Factor IX Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Coagulation Factor IX Sales in Value by Region (2024-2029)
8 Latin America Coagulation Factor IX by Country
8.1 Latin America Coagulation Factor IX Historic Market Size by Country
8.1.1 Latin America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Coagulation Factor IX Sales in Volume by Country (2018-2023)
8.1.3 Latin America Coagulation Factor IX Sales in Value by Country (2018-2023)
8.2 Latin America Coagulation Factor IX Forecasted Market Size by Country
8.2.1 Latin America Coagulation Factor IX Sales in Volume by Country (2024-2029)
8.2.2 Latin America Coagulation Factor IX Sales in Value by Country (2024-2029)
9 Middle East and Africa Coagulation Factor IX by Country
9.1 Middle East and Africa Coagulation Factor IX Historic Market Size by Country
9.1.1 Middle East and Africa Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Coagulation Factor IX Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Coagulation Factor IX Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Coagulation Factor IX Forecasted Market Size by Country
9.2.1 Middle East and Africa Coagulation Factor IX Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Coagulation Factor IX Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Coagulation Factor IX Products Offered
10.1.5 Pfizer Recent Development
10.2 CSL Behring
10.2.1 CSL Behring Company Information
10.2.2 CSL Behring Introduction and Business Overview
10.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Behring Coagulation Factor IX Products Offered
10.2.5 CSL Behring Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Coagulation Factor IX Products Offered
10.3.5 Grifols Recent Development
10.4 Novo Nordisk
10.4.1 Novo Nordisk Company Information
10.4.2 Novo Nordisk Introduction and Business Overview
10.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novo Nordisk Coagulation Factor IX Products Offered
10.4.5 Novo Nordisk Recent Development
10.5 Bioverativ
10.5.1 Bioverativ Company Information
10.5.2 Bioverativ Introduction and Business Overview
10.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bioverativ Coagulation Factor IX Products Offered
10.5.5 Bioverativ Recent Development
10.6 Sanquin
10.6.1 Sanquin Company Information
10.6.2 Sanquin Introduction and Business Overview
10.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanquin Coagulation Factor IX Products Offered
10.6.5 Sanquin Recent Development
10.7 Takeda
10.7.1 Takeda Company Information
10.7.2 Takeda Introduction and Business Overview
10.7.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Takeda Coagulation Factor IX Products Offered
10.7.5 Takeda Recent Development
10.8 Baxter
10.8.1 Baxter Company Information
10.8.2 Baxter Introduction and Business Overview
10.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Baxter Coagulation Factor IX Products Offered
10.8.5 Baxter Recent Development
10.9 Aptevo
10.9.1 Aptevo Company Information
10.9.2 Aptevo Introduction and Business Overview
10.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Aptevo Coagulation Factor IX Products Offered
10.9.5 Aptevo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Coagulation Factor IX Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Coagulation Factor IX Industrial Chain Analysis
11.4 Coagulation Factor IX Market Dynamics
11.4.1 Coagulation Factor IX Industry Trends
11.4.2 Coagulation Factor IX Market Drivers
11.4.3 Coagulation Factor IX Market Challenges
11.4.4 Coagulation Factor IX Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Coagulation Factor IX Distributors
12.3 Coagulation Factor IX Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
